Glenmark recalls ADHD medicine bottles in US

Glenmark recalls ADHD medicine bottles in US
Representative image
Glenmark Pharma is recalling close to 15 lakh bottles of a generic medication used in the treatment of ADHD in the US market, the US health regulator said. The company is recalling the lot due to "CGMP deviations", the regulator USFDA said. The recall is due to "presence of N-Nitroso Atomoxetine impurity above the FDA recommended limit," it added. agencies
End of Article
FOLLOW US ON SOCIAL MEDIA